Research & development increased 28.1%
Research & development changed +28.1% from the comparable as-filed period.
$346.7M→$444.2M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CRWD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stock-based compensation increased 31.3%
Stock-based compensation changed +31.3% from the comparable as-filed period.
$287.2M→$376.9M2 prior comparisons
Total assets increased 29.5%
Total assets changed +29.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$9.3B→$12.0B4 prior comparisons
Gross profit increased 27.7%
Gross profit changed +27.7% from the comparable as-filed period.
$858.7M→$1.1B2 prior comparisons
Current liabilities increased 27.4%
Current liabilities changed +27.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.5B→$4.4B4 prior comparisons
Current ratio decreased 16.5%
Current ratio changed -16.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
1.88→1.574 prior comparisons
Net income changed across a sign change
Net income changed +106.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
-$77.7M→$5.3M2 prior comparisons
Trade receivables increased 17.1%
Trade receivables changed +17.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$886.6M→$1.0B4 prior comparisons
Working capital decreased 17.4%
Working capital changed -17.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.1B→$2.5B4 prior comparisons
Current assets increased 6.4%
Current assets changed +6.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$6.5B→$7.0B4 prior comparisons
Cash & equivalents increased 0.8%
Cash & equivalents changed +0.8% from the comparable as-filed period.
$5.0B→$5.0B2 prior comparisons
Noncurrent long-term debt increased 0.2%
Noncurrent long-term debt changed +0.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$744.7M→$746.2M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.